CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

A COPD drug from China draws $115M in venture funding

Positive
AI Analysis

Summary

Expedition Therapeutics raised $115M in venture funding for a COPD drug it believes has notable advantages over existing treatments. The company has raised nearly $300M to date.

Importance:5/10
Sentiment:
0.60
venture fundingCOPDChinadrug development
Related Companies

Read the original article

Published by BioPharma Dive on August 5, 2026 12:00 PM

Read Original